Login to Your Account



Biosimilar MAbs Starting to Line Up for Approval

By Sharon Kingman
Staff Writer

Wednesday, February 20, 2013
LONDON – 2013 will be a watershed year for biosimilars – biological therapies designed to be similar to existing biological therapeutic agents – delegates attending the Second Biosimilars Congregation in London heard Tuesday.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription